1
|
Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3.
|
FEBS J
|
2007
|
0.92
|
2
|
Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
|
Antivir Ther
|
2007
|
0.85
|
3
|
Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.
|
Bioorg Med Chem
|
2003
|
0.84
|
4
|
Structure-activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V.
|
Antivir Ther
|
2010
|
0.81
|
5
|
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.
|
Bioorg Med Chem
|
2005
|
0.80
|
6
|
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.
|
Bioorg Med Chem
|
2007
|
0.78
|
7
|
Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3.
|
J Enzyme Inhib Med Chem
|
2007
|
0.75
|
8
|
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).
|
Bioorg Med Chem
|
2002
|
0.75
|
9
|
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.
|
Biochim Biophys Acta
|
2004
|
0.75
|